Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
about
KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancerSilencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinomaKIF14 negatively regulates Rap1a-Radil signaling during breast cancer progressionRegulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development.Weighted frequent gene co-expression network mining to identify genes involved in genome stability.The motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinomaIdentification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm.The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells.Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancerDownregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.Oncogenic role of kinesin proteins and targeting kinesin therapy.The genomic landscape of retinoblastoma: a review.RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Targeting mitotic pathways for endocrine-related cancer therapeutics.The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.Suppression of KIF14 expression inhibits hepatocellular carcinoma progression and predicts favorable outcome.The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?Mutations of KIF14 Cause Primary Microcephaly by Impairing Cytokinesis.Kinesin family member 14 in human oral cancer: A potential biomarker for tumoral growth.Biallelic variants in KIF14 cause intellectual disability with microcephaly.Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.Sox17 inhibits hepatocellular carcinoma progression by downregulation of KIF14 expression.Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.Observations on spontaneous tumor formation in mice overexpressing mitotic kinesin Kif14KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer
P2860
Q24296484-9E72C77C-B04F-4BF5-8AD1-FC7DEBB892BFQ24298070-6F62853A-EEB3-40A2-9BFD-F2344FB276BEQ24305208-5BEC8A08-7172-4C1B-9CB9-0C0E4620E1FEQ34159585-E0DE42DB-2F9D-432F-B783-FC81E2B92282Q34407753-72449EEB-729A-43E0-A1BB-A801E33D2406Q34692260-9D2B8DAE-E38E-4A99-87B6-7E961EBC41CAQ34743854-F7FE4EF2-B986-4FFD-B3D3-25C290E20513Q34998666-31BDC3BD-013C-4A65-999A-5978157DBB24Q35120277-85075B13-AD2B-4346-8ED8-3BCE504D94CAQ35886083-89B0E196-E331-4BFB-A90A-DC58DBFC5253Q36765087-787B7461-45C2-4E18-972E-316D3274C44EQ37190159-458412AA-D762-4D3A-9BB8-A5697BE91BE5Q38084376-B3CC9B60-7BA9-40F9-A7F7-E7D5FC8CD870Q38179069-DF5C4582-6C37-4976-B3F8-1700CE3CE9A1Q38432883-F86D7CA9-4FB7-48D7-AE5F-430FB2562182Q38671036-D622BC79-2681-4F56-8F05-4217B016ECC4Q38703533-3B9D06CC-54C1-40AC-AD61-5788D0A65A12Q38737328-42293774-4D5B-40A2-A719-FDC986B693BCQ38774648-FA626CD6-EED0-4C8D-A938-94D9E1A5B0B7Q39193699-448695E5-F47C-4428-ADC8-BCDB2B433FD1Q39198605-AA3619FD-E792-41D4-9ECA-5BBCAACF7A54Q39512476-C5A702F0-BC82-47D8-B125-7BA12F8588F2Q41918448-E5CFC712-B2CF-438C-8257-28F0F4AB190BQ47094090-37D57EC5-969B-42DA-B4DC-161FACEAB3EFQ47855383-F1E79A58-5DFE-4C36-84F4-0ED02CB5FFEEQ51035956-3B09FC4C-B176-4034-99AD-CA2E859E85E3Q51064043-23B7C735-5198-429B-B7F9-85285C9824ADQ55425029-7B5BE1D0-E071-4D17-8623-286265F3C42DQ58370838-A9F95C38-9295-4698-9227-C0D3BAD04076Q58692278-351CE378-4C86-4BC8-BE01-890262A5C199
P2860
Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@en
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@nl
type
label
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@en
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@nl
prefLabel
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@en
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@nl
P2093
P2860
P356
P1476
Kinesin family member 14: an i ...... tic target for ovarian cancer.
@en
P2093
Brigitte L Thériault
Marcus Q Bernardini
Patricia A Shaw
Sanja Pajovic
P2860
P304
P356
10.1002/IJC.26189
P577
2011-08-05T00:00:00Z